Growing community of inventors

Paris, France

Matthew P Pando

Average Co-Inventor Count = 6.43

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 4

Matthew P PandoJohn E Donello (4 patents)Matthew P PandoRong Yang (4 patents)Matthew P PandoBertrand Leblond (4 patents)Matthew P PandoThierry Taverne (4 patents)Matthew P PandoEric Beausoleil (4 patents)Matthew P PandoAnne-Sophie Casagrande (4 patents)Matthew P PandoLaurent Desire (3 patents)Matthew P PandoCedric Chauvignac (3 patents)Matthew P PandoCédric Chauvignac (1 patent)Matthew P PandoLaurent Désiré (1 patent)Matthew P PandoRichard Einstein (1 patent)Matthew P PandoKevin M McGowan (1 patent)Matthew P PandoMatthew P Pando (5 patents)John E DonelloJohn E Donello (136 patents)Rong YangRong Yang (28 patents)Bertrand LeblondBertrand Leblond (23 patents)Thierry TaverneThierry Taverne (16 patents)Eric BeausoleilEric Beausoleil (16 patents)Anne-Sophie CasagrandeAnne-Sophie Casagrande (5 patents)Laurent DesireLaurent Desire (6 patents)Cedric ChauvignacCedric Chauvignac (3 patents)Cédric ChauvignacCédric Chauvignac (2 patents)Laurent DésiréLaurent Désiré (1 patent)Richard EinsteinRichard Einstein (1 patent)Kevin M McGowanKevin M McGowan (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Exonhit Therapeutics, Sa (5 from 25 patents)

2. Allergan, Inc. (4 from 2,285 patents)


5 patents:

1. 9902710 - Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)

2. 9670181 - Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)

3. 9200016 - Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)

4. 8772316 - Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE10A)

5. 7834163 - Prostate specific genes and the use thereof as targets for prostate cancer therapy

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/14/2025
Loading…